Interpath Laboratory, INC.

Interpath Laboratory, INC. was paid $70.05M by Medicaid between Jan 2018 and Dec 2024, across 333 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 13% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Oregon

Rank by total paid#1 of 46

Median peer was paid$50K

This provider vs. median1,404×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	549,041	$6.20M
2019	612,426	$6.88M
2020	744,381	$11.08M
2021	932,345	$13.94M
2022	950,914	$12.39M
2023	860,521	$10.05M
2024incomplete	768,992	$9.51M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	13%	126,446	118,139	$8.78M
80050	General health panel	8.0%	187,675	181,027	$5.58M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.9%	118,097	112,866	$3.43M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.9%	118,191	112,992	$3.41M
80061	Lipid panel	3.5%	265,927	251,292	$2.46M
84443	Thyroid stimulating hormone (TSH)	3.0%	183,557	171,210	$2.11M
80053	Comprehensive metabolic panel	2.6%	267,950	244,395	$1.83M
36415	Collection of venous blood by venipuncture	2.5%	514,171	456,548	$1.77M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.3%	311,128	280,400	$1.64M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.3%	35,608	30,569	$1.58M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	2.1%	75,716	73,384	$1.49M
83036	Hemoglobin; glycosylated (A1C)	2.1%	227,579	216,223	$1.48M

321 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.9%	84,733	$1.30M
87481		1.8%	27,922	$1.28M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.7%	43,747	$1.22M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.6%	16,096	$1.15M
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.6%	48,385	$1.14M
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.5%	36,349	$1.03M
86481		1.3%	11,994	$888K
87086	Culture, bacterial; quantitative colony count, urine	1.1%	131,793	$800K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.1%	21,798	$789K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.0%	57,365	$730K
86780		<1%	65,694	$691K
86003		<1%	8,037	$675K
86803		<1%	59,913	$675K
84439		<1%	103,587	$653K
82728		<1%	64,364	$620K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,057	$585K
84403		<1%	30,155	$555K
83013		<1%	8,770	$493K
84466		<1%	52,978	$482K
87653		<1%	15,393	$458K
82607		<1%	44,451	$448K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	16,012	$441K
81513		<1%	23,761	$436K
86235		<1%	6,377	$431K
87340		<1%	51,223	$410K
87077		<1%	62,308	$379K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	25,572	$348K
84153		<1%	26,518	$322K
82746		<1%	31,315	$320K
87186		<1%	52,486	$318K
87902		<1%	1,679	$299K
84481		<1%	25,577	$298K
87511		<1%	16,376	$283K
84702		<1%	22,338	$279K
84270		<1%	17,767	$279K
82570		<1%	85,853	$279K
80048	Basic metabolic panel (calcium, ionized)	<1%	53,264	$275K
82670		<1%	12,999	$266K
86762		<1%	21,841	$265K
87632		<1%	1,572	$258K
83540		<1%	55,015	$252K
82043		<1%	58,167	$232K
86706		<1%	27,294	$224K
87070		<1%	33,983	$223K
81001		<1%	96,297	$218K
83516		<1%	24,148	$217K
83001		<1%	14,719	$209K
86850		<1%	28,908	$208K
87480		<1%	13,134	$207K
87510		<1%	13,130	$207K
87660		<1%	13,139	$206K
82274		<1%	15,123	$201K
86704		<1%	22,073	$200K
83970		<1%	9,011	$199K
83655		<1%	17,158	$196K
83880		<1%	9,540	$190K
86038		<1%	20,193	$184K
87046		<1%	11,368	$181K
87522	Neg quan hep c or qual rna	<1%	6,890	$181K
84146		<1%	11,675	$175K
87521	Neg quan hep c or qual rna	<1%	7,073	$175K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	1,545	$172K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,686	$170K
87536		<1%	3,066	$170K
83002		<1%	11,357	$162K
86696		<1%	10,511	$152K
86140		<1%	38,344	$142K
84144		<1%	8,868	$137K
87081		<1%	22,671	$135K
80074		<1%	3,705	$131K
82105		<1%	8,959	$124K
87529		<1%	2,285	$120K
85651		<1%	39,495	$115K
86787		<1%	10,655	$114K
86376		<1%	10,661	$114K
87631		<1%	1,198	$102K
82627		<1%	6,453	$102K
88141		<1%	5,359	$100K
86800		<1%	8,664	$100K
87493		<1%	4,107	$99K
87338		<1%	8,472	$98K
87088		<1%	17,894	$98K
86695		<1%	9,612	$96K
86665		<1%	5,937	$95K
87210		<1%	19,707	$92K
87209		<1%	6,350	$90K
84703		<1%	13,690	$89K
86709		<1%	10,672	$87K
83690		<1%	15,756	$84K
83735		<1%	20,576	$83K
82950		<1%	19,837	$81K
86317		<1%	5,417	$80K
86141		<1%	8,003	$76K
86360		<1%	2,004	$76K
82784		<1%	8,913	$75K
87535		<1%	2,598	$74K
82671		<1%	2,867	$70K
82951		<1%	6,195	$69K
86900		<1%	27,945	$68K
86694		<1%	6,086	$67K
86901		<1%	27,957	$67K
86431		<1%	15,303	$67K
82533		<1%	5,741	$64K
82677		<1%	2,927	$63K
83525		<1%	7,579	$63K
86359		<1%	2,005	$61K
81003		<1%	29,790	$60K
87205		<1%	19,108	$59K
80076		<1%	11,083	$59K
86160		<1%	7,061	$56K
84480		<1%	6,136	$54K
84550		<1%	17,856	$54K
85027		<1%	12,157	$52K
85610		<1%	21,812	$52K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,224	$50K
87045		<1%	6,667	$49K
86200		<1%	4,789	$47K
87177		<1%	6,416	$45K
86682		<1%	3,538	$45K
84154		<1%	4,252	$44K
83721		<1%	8,117	$43K
87075		<1%	6,292	$43K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	801	$42K
86336		<1%	2,827	$39K
82150		<1%	7,612	$39K
80164		<1%	5,295	$38K
83520		<1%	2,939	$36K
84436		<1%	8,406	$36K
88142		<1%	1,813	$35K
82785		<1%	3,043	$34K
83090		<1%	2,959	$34K
87517		<1%	986	$33K
84425		<1%	2,562	$33K
82024		<1%	1,335	$33K
84681		<1%	2,294	$33K
86735		<1%	2,736	$32K
86765		<1%	2,762	$31K
83993		<1%	2,115	$31K
86708		<1%	3,040	$30K
80069		<1%	6,582	$29K
82140		<1%	3,340	$29K
85014		<1%	12,647	$28K
84156		<1%	11,504	$27K
86060		<1%	4,596	$26K
80178		<1%	5,787	$26K
82977		<1%	5,910	$26K
87516		<1%	835	$25K
80305		<1%	2,330	$25K
83519		<1%	1,983	$25K
83498		<1%	1,245	$25K
87147		<1%	4,208	$25K
86769		<1%	1,372	$25K
85379		<1%	3,450	$25K
84479		<1%	5,391	$24K
87420		<1%	1,994	$24K
86664		<1%	2,146	$24K
84445		<1%	689	$24K
82550		<1%	5,570	$24K
36416		<1%	9,322	$23K
86812		<1%	1,237	$23K
84482		<1%	2,122	$23K
82247		<1%	5,602	$23K
87329		<1%	2,464	$23K
84460		<1%	5,447	$22K
85730		<1%	5,137	$22K
84100		<1%	7,935	$22K
82652		<1%	969	$21K
86318		<1%	1,599	$21K
86663		<1%	2,161	$21K
84484		<1%	2,315	$20K
86592		<1%	6,036	$19K
84207		<1%	1,231	$19K
84402		<1%	1,035	$19K
88342		<1%	242	$18K
86308		<1%	3,896	$17K
82952		<1%	4,744	$16K
84630		<1%	2,125	$16K
86645		<1%	1,214	$16K
87634		<1%	380	$16K
84450		<1%	4,174	$16K
82248		<1%	3,690	$15K
85018		<1%	6,749	$14K
82310		<1%	9,298	$14K
82947		<1%	4,283	$14K
86644		<1%	1,205	$13K
82525		<1%	1,612	$13K
82239		<1%	906	$13K
80159		<1%	1,569	$13K
83615		<1%	3,627	$12K
86747		<1%	501	$12K
80503		<1%	1,722	$12K
84165		<1%	1,944	$12K
83088		<1%	534	$11K
83921		<1%	882	$11K
88312		<1%	220	$11K
85045		<1%	4,058	$11K
80177		<1%	1,483	$11K
81015		<1%	8,026	$11K
80197		<1%	1,448	$10K
86256		<1%	1,150	$10K
82390		<1%	1,287	$10K
83021		<1%	592	$9K
82172		<1%	757	$9K
83704		<1%	437	$9K
80175		<1%	1,180	$9K
86304		<1%	679	$8K
82365		<1%	917	$8K
86147		<1%	212	$8K
85060		<1%	608	$8K
81050		<1%	3,267	$7K
87252		<1%	350	$7K
83883		<1%	795	$7K
85245		<1%	420	$7K
80500		<1%	621	$6K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	2,422	$6K
88304		<1%	181	$6K
86255		<1%	747	$6K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	127	$6K
86870		<1%	248	$6K
82565		<1%	1,964	$6K
84075		<1%	2,532	$5K
86341		<1%	320	$5K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	38	$5K
86593		<1%	839	$5K
87220		<1%	1,272	$5K
80156		<1%	641	$5K
87109		<1%	566	$5K
84134		<1%	568	$5K
86777		<1%	422	$5K
82088		<1%	168	$5K
82330		<1%	551	$5K
99001		<1%	1,772	$5K
87102		<1%	735	$5K
84520		<1%	1,952	$4K
87076		<1%	628	$4K
83020		<1%	376	$4K
86617		<1%	161	$4K
87185		<1%	837	$3K
85613		<1%	511	$3K
85240		<1%	250	$3K
84244		<1%	213	$3K
87184		<1%	871	$3K
82378		<1%	322	$3K
84155		<1%	1,912	$3K
82553		<1%	292	$3K
85246		<1%	136	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	2,962	$2K
82948		<1%	579	$2K
86778		<1%	190	$2K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	1,275	$2K
87276		<1%	157	$2K
83695		<1%	187	$2K
82340		<1%	395	$2K
87641		<1%	80	$1K
84590		<1%	199	$1K
87275		<1%	157	$1K
80185		<1%	243	$1K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	13,903	$1K
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	<1%	716	$1K
82653		<1%	56	$1K
87040		<1%	177	$1K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	1,086	$1K
83789		<1%	80	$1K
83521		<1%	44	$1K
82626		<1%	63	$1K
86618		<1%	120	$1K
82103		<1%	128	$1K
87280		<1%	122	$1K
84132		<1%	398	$1K
81241		<1%	59	$1K
84300		<1%	331	$1K
87328		<1%	91	$963.65
86334		<1%	99	$938.04
81269		<1%	56	$914.78
87260		<1%	90	$864.33
83835		<1%	78	$845.89
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	9,539	$763.73
83986		<1%	331	$727.49
87279		<1%	118	$653.29
86702		<1%	69	$644.03
84311		<1%	141	$599.12
86361		<1%	28	$529.74
84140		<1%	52	$515.42
83945		<1%	53	$475.76
83874		<1%	44	$442.01
86701		<1%	69	$421.88
81291		<1%	186	$418.47
86658		<1%	14	$396.48
82465		<1%	131	$387.04
80162		<1%	124	$382.47
84478		<1%	84	$378.14
87181		<1%	175	$377.20
82157		<1%	14	$369.66
82040		<1%	137	$317.12
87350		<1%	25	$262.02
82542		<1%	15	$258.66
86788		<1%	21	$245.18
84133		<1%	81	$244.85
82507		<1%	15	$230.74
86335		<1%	13	$211.26
83630		<1%	20	$210.79
85049		<1%	57	$188.79
86789		<1%	19	$187.05
82397		<1%	14	$173.45
85306		<1%	14	$172.85
82530		<1%	16	$172.45
82436		<1%	42	$146.57
84432		<1%	12	$141.84
84105		<1%	38	$136.16
84560		<1%	40	$134.42
82955		<1%	14	$130.32
82668		<1%	12	$124.85
87341		<1%	13	$112.35
86707		<1%	13	$98.79
85384		<1%	14	$96.70
86705		<1%	15	$89.32
83718		<1%	13	$87.06
86001		<1%	12	$77.54
84446		<1%	12	$73.72
84392		<1%	14	$41.70
84145		0%	90	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMANDELLA, GOLDIE (MANAGER, BILLING OPERATIONS)